SUMMIT THERAPEUTICS INC COM - Stock (SMMT)

Historical Holders from Q1 2015 to Q3 2025

Type / Class
Equity / Stock
Symbol
SMMT on Nasdaq
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
0
Total reported value
$0
Share change
-3,831
Value change
-$81,523
Avg sell value change
-0%
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
As of 30 Sep 2025, SUMMIT THERAPEUTICS INC COM - Stock (SMMT) has 0 institutional shareholders filing 13F forms. They reported no common stock holdings, but disclosed options positions.

Institutional Holders of SUMMIT THERAPEUTICS INC COM - Stock (SMMT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q3 0 $0 -$81,523 0
2025 Q2 3,831 $81,523 +$50,630 2,127.98% 12
2025 Q1 2,320 $44,431 -$161,205 1,928.75% 10
2024 Q4 11,418 $203,755 +$187,963 1,784.5% 7
2024 Q3 885 $19,382 +$417 2,190.04% 2
2024 Q2 866 $6,755 +$2,558 780.01% 2
2024 Q1 548 $2,268 -$28,509 411.78% 2
2023 Q4 11,483 $29,970 -$665 260.96% 2
2023 Q3 11,738 $21,950 -$90,673 186.98% 2
2023 Q2 47,852 $120,108 -$8,711 250.98% 4
2023 Q1 51,994 $90,990 +$81,319 175% 6
2022 Q4 5,526 $23,486 -$10,764 425% 4
2022 Q3 16,245 $19,000 +$2,435 115.61% 3
2022 Q2 14,445 $14,000 +$192 100% 3
2022 Q1 14,245 $34,000 +$5,000 249% 3
2021 Q4 11,245 $30,000 -$3,000 266.79% 1
2021 Q3 11,930 $59,000 -$5,756 473.93% 3
2021 Q2 12,983 $96,000 +$9,263 700.98% 4
2021 Q1 11,674 $68,000 -$240,570 570.13% 3
2020 Q4 62,690 $295,000 -$30,000 472.73% 5
2020 Q3 68,600 $235,000 -$24,104,008 342.11% 3
2020 Q2 8,186,422 $24,313,970 -$659,821 296.78% 18
2020 Q1 8,401,772 $19,917,000 +$13,659,867 237.13% 10
2019 Q4 2,743,688 $4,389,000 +$131,027 159.98% 11
2019 Q3 2,657,174 $4,756,000 -$8,606 178.99% 10
2019 Q2 2,662,960 $3,369,000 +$56,120 126.53% 8
2019 Q1 2,593,858 $4,748,000 -$216,604 183.01% 11
2018 Q4 2,881,399 $3,313,000 -$171,212 114.98% 8
2018 Q3 2,716,831 $6,030,000 -$1,187,761 221.9% 11
2018 Q2 3,222,086 $7,894,000 -$8,096,673 244.99% 13
2018 Q1 4,143,303 $53,319,000 +$2,089,366 1,290% 19
2017 Q4 4,017,625 $44,513,000 -$755,139 1,108% 20
2017 Q3 4,054,940 $50,865,000 +$17,110,037 1,254.98% 20
2017 Q2 2,690,736 $30,479,000 -$62,231 1,133.36% 14
2017 Q1 2,694,940 $35,802,000 -$9,122 1,328.1% 15
2016 Q4 2,695,646 $23,072,000 -$269,384 855.83% 11
2016 Q3 2,727,116 $24,762,000 -$66,243 906.43% 12
2016 Q2 2,734,292 $21,923,000 -$365,239 790.81% 10
2016 Q1 2,669,891 $18,277,000 -$323,117 682.08% 8
2015 Q4 2,835,071 $32,595,000 -$36,517 1,149.93% 10
2015 Q3 2,838,493 $29,548,000 +$990,258 1,040.96% 10
2015 Q2 0 $0 -$1,724,002 0
2015 Q1 2,680,373 $33,209,000 +$33,208,973 1,238.94% 7